We are live on ! Find out more
INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

116 hedge funds and large institutions have $175M invested in Insys Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 24

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

2% less funds holding

Funds holding: 118 → 116 (-2)

29% less capital invested

Capital invested by funds: $246M → $175M (-$71.4M)

46% less call options, than puts

Call options by funds: $2.36M | Put options by funds: $4.4M

Holders
116
Holders Change
-2
Holders Change %
-1.69%
% of All Funds
2.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
37
Reduced
24
Closed
22
Calls
$2.36M
Puts
$4.4M
Net Calls
-$2.03M
Net Calls Change
-$303K

Top Buyers

Rank Fund Capital Flow
1
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$4.12M
2
Invesco
Invesco
Georgia
+$2.73M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.81M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.16M
5
PAM
Panagora Asset Management
Massachusetts
+$1.1M

Top Sellers

Rank Fund Capital Flow
1
FHAM
Folger Hill Asset Management
New York
-$3.96M
2
Credit Agricole
Credit Agricole
France
-$2.31M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$1.14M
4
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
-$1.11M
5
GAM
Gotham Asset Management
New York
-$892K
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
26
Shell Asset Management
Netherlands
$845K +$628K +60,904 +178%
SC
27
Sculptor Capital
New York
$789K +$916K +88,800 New
GH
28
GAM Holding
Switzerland
$745K – – –
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$670K – – –
AllianceBernstein
30
AllianceBernstein
Tennessee
$604K -$751K -72,820 -52%
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$582K -$59.9K -5,804 -8%
TCIM
32
TIAA CREF Investment Management
New York
$569K – – –
FIM
33
Freedom Investment Management
Connecticut
$560K -$31.9K -3,089 -5%
JP Morgan Chase
34
JP Morgan Chase
New York
$508K +$43.7K +4,231 +8%
TA
35
Teachers Advisors
New York
$400K – – –
HK
36
Horizon Kinetics
New York
$393K +$92.6K +8,971 +25%
ProShare Advisors
37
ProShare Advisors
Maryland
$378K +$35.6K +3,451 +9%
Wells Fargo
38
Wells Fargo
California
$368K +$143K +13,849 +50%
Cambridge Investment Research Advisors
39
Cambridge Investment Research Advisors
Iowa
$359K +$25.9K +2,509 +7%
DekaBank Deutsche Girozentrale
40
DekaBank Deutsche Girozentrale
Germany
$357K – – –
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$335K -$49.2K -4,765 -11%
GCP
42
GSA Capital Partners
United Kingdom
$330K -$118K -11,400 -23%
Swiss National Bank
43
Swiss National Bank
Switzerland
$319K – – –
WMSA
44
Weiss Multi-Strategy Advisers
New York
$306K -$103K -10,000 -22%
Bank of America
45
Bank of America
North Carolina
$305K +$74.8K +7,249 +27%
CS
46
Credit Suisse
Switzerland
$295K +$125K +12,087 +57%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$283K +$9.03K +875 +3%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$258K +$159K +15,407 +113%
LCM
49
Landscape Capital Management
New Jersey
$254K +$296K +28,650 New
Deutsche Bank
50
Deutsche Bank
Germany
$220K -$677K -65,618 -72%
1
2
3 4 5

INSY Hedge Fund Activity: Q3 2017 in Review

116 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Insys Therapeutics, Inc. (INSY) for Q3 2017, worth a combined $175M — down 29% from $246M a quarter earlier.

Fund positioning in INSY was balanced in Q3 2017: 22 funds opened new positions, 22 closed out, 37 added to existing stakes and 24 trimmed.

The largest buyer was Mirae Asset Global Investments, adding an estimated $4.12M. The largest seller was Folger Hill Asset Management, cutting an estimated $3.96M.

  • 116 institutional investors held Insys Therapeutics, Inc. (INSY) as of Q3 2017, down from 118 in Q2 2017.
  • Funds reported $175M of Insys Therapeutics, Inc. stock for Q3 2017, down 29% quarter-over-quarter.
  • 22 funds opened new Insys Therapeutics, Inc. positions in Q3 2017 and 22 closed out, a net change of 0 holders.
  • The largest Insys Therapeutics, Inc. buyer in Q3 2017 was Mirae Asset Global Investments, an estimated $4.12M added.
  • The largest Insys Therapeutics, Inc. seller in Q3 2017 was Folger Hill Asset Management, an estimated $3.96M sold.

Based on aggregated 13F filings for Q3 2017.